|
201 |
Annual Report 2021-22 |
|
|
202 |
Invitation of Applications for the posts of Director of NIPER- Ahmedabad and NIPER-Raebareli |
|
|
203 |
Invitation of Applications under the PLI Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials(KSMs)/Drug Intermediates and Active Pharmaceuticals Ingredients (APIs) - extension till 30.04.2022 |
|
|
204 |
Notice: PPDS scheme for FY 21-22 - Selection of agencies for conducting studies (Long Term and Short Term) - reg. |
|
|
205 |
Portal for India Pharma and India Medical Device Awards |
|
|
206 |
Timeline Extension for filling applications under PLI Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials(KSMs)/Drug Intermediates and Active Pharmaceuticals Ingredients (APIs) upto 31.03.2022 |
|
|
207 |
Guidelines for the Scheme for Strengthening of Pharmaceuticals Industry (SPI) |
|
|
208 |
Guidelines regarding Awards to the leading Pharma and Medical Devices Industry players - India Pharma 2022 & India Medical Devices 2022. |
|
|
209 |
Notice regarding Awards to the leading Pharma and Medical Devices Industry players - India Pharma 2022 & India Medical Devices 2022 |
|
|
210 |
Public Notice dated 28.02.2022 :Inviting details of local manufacturers of specific Drugs -reg. |
|
|
211 |
List of approved applicants under PLI Scheme for Bulk Drug (Dated :20-01-2021) |
|
|
212 |
Public Notice dated 01.02.2022: Relaxation on Global Tender Enquiry (GTE) under Rule 161(iv) of General Financial Rules (GFRs) 2017 for procurement of Medical Devices - reg. |
|
|
213 |
Hiring of Technical Consultant for Pharmaceuticals and Medical Devices. |
|
|
214 |
Invitation of Applications under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/Drug Intermediates and Active Pharmaceuticals Ingredients (APIs) in the Country |
|
|
215 |
List of approved applicants under PLI Scheme for Medical Devices |
|
|
216 |
Press Notes regarding Approvals accorded under PLI Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the country. Dated: 9th December, 2021 |
|
|
217 |
Press Notes regarding Approval accorded under PLI Scheme for Promotion of Domestic Manufacturing of Medical Devices. Dated: 9th December, 2021 |
|
|
218 |
List of Approved Applicants under Production Linked Incentive (PLI) Scheme for Pharmaceuticals |
|
|
219 |
List of Approved Applicants under the the Production Linked Incentive (PLI) scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates (DIs)/ Active Pharmaceutical Ingredients (APIs) in India |
|
|
220 |
Inviting details of local manufacturers of specific medical devices/equipments |
|
|
221 |
Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding. |
|
|
222 |
Press Release regarding Selection of applicants under the Production Linked Incentive (PLI) scheme for Pharmaceuticals |
|
|
223 |
Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding. |
|
|
224 |
FAQ: Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof |
|
|
225 |
Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding. |
|
|
226 |
Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding. |
|
|
227 |
Corrigendum: R.F.P. for Short Term Study and Long Term Study -Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof. |
|
|
228 |
Regarding- Draft Policy to Catalyze Research & Development and Innovation in the Pharma - MedTech Sector in India |
|
|
229 |
Circulation of Draft Policy to Catalyze Research & Development and Innovation in the Pharma- MedTech Sector in India |
|
|
230 |
R.F.P. for Long Term Study- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof. |
|
|
231 |
R.F.P. for Short Term Study- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof. |
|
|
232 |
Filling up the post of Managing Director, Bengal Chemicals & Pharmaceuticals Limited (BCPL) on deputation basis through Search-cum-Selection Committee (SCSC). |
|
|
233 |
Corrigendum under PLI scheme for Pharmaceuticals |
|
|
234 |
Filling up the post of Chief Executive Officer (CEO) in the Pharmaceutical and Medical Devices Bureau of India (PMBI), a Society under the aegis of Department of Pharmaceuticals, Government of India on deputation including short term contract. |
|
|
235 |
Invitation of Applications for Ofloxacin under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in India. |
|
|
236 |
Notice for Time Extension of PLI for Bulk Drug and PLI for Medical Devices |
|
|
237 |
Notification regarding the revision of ceiling prices under para 18(i) of the Drugs (Prices Control) Order, 2013. |
|
|
238 |
Corrigendum- Operational Guidelines of PLI scheme for Pharmaceuticals |
|
|
239 |
Engagement of 04 Consultant(Non-tech, SO level) in the Department of Pharmaceuticals- reg |
|
|
240 |
Revised Notice- Invitation of Applications under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the Country |
|
|
241 |
Corrigendum- Operational Guidelines of PLI scheme for Pharmaceuticals |
|
|
242 |
Annual Report 2020-21 |
|
|
243 |
Observing the 7th International Yoga Day, 2021. |
|
|
244 |
Revised Notice- Invitation of Applications Under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the Country |
|
|
245 |
Revised Notice- Invitation of Applications Under the Production Linked Incentive (PLI) Scheme for Promoting Domestic Manufacturing of Medical Devices. |
|
|
246 |
Allocation of Tocilizumab Dated 11th May 2021 |
|
|
247 |
State-wise allocation of Remdesivir vials for period 21st April to 16th May, 2021 |
|
|
248 |
Revised allocation of Tocilizumab to States |
|
|
249 |
State-wise allocation of Remdesivir vials for period 21st April to 9th May, 2021 |
|
|
250 |
Order dated 25.03.2021 regarding items having sufficient local capacity and local competition as per Para 3(a) of revised Public Procurement (Preference to Make in India) Order dated 16.09.2020 |
|
औषध विभाग
Department of
